Â¥
6.20
Apr 26
Business Description
Guangdong Hybribio Biotech Co Ltd
ISIN : CNE100002N51
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 18.92 | |||||
Equity-to-Asset | 0.85 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 1.36 | |||||
Interest Coverage | 1.98 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 5.33 | |||||
Beneish M-Score | -1.03 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -3.8 | |||||
3-Year EBITDA Growth Rate | -22.4 | |||||
3-Year EPS without NRI Growth Rate | -29.7 | |||||
3-Year Book Growth Rate | 27.6 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 49.9 | |||||
9-Day RSI | 41.95 | |||||
14-Day RSI | 40.1 | |||||
6-1 Month Momentum % | -18.92 | |||||
12-1 Month Momentum % | -24.62 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.25 | |||||
Quick Ratio | 6.06 | |||||
Cash Ratio | 2.11 | |||||
Days Inventory | 96.37 | |||||
Days Sales Outstanding | 773.56 | |||||
Days Payable | 231.6 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 5.78 | |||||
Dividend Payout Ratio | 1.67 | |||||
3-Year Dividend Growth Rate | 70.2 | |||||
Forward Dividend Yield % | 5.78 | |||||
5-Year Yield-on-Cost % | 29.67 | |||||
3-Year Average Share Buyback Ratio | 0.7 | |||||
Shareholder Yield % | 6.32 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 61.03 | |||||
Operating Margin % | 0.89 | |||||
Net Margin % | 12.72 | |||||
FCF Margin % | -5.95 | |||||
ROE % | 2.87 | |||||
ROA % | 2.25 | |||||
ROIC % | 0.43 | |||||
ROC (Joel Greenblatt) % | 1.33 | |||||
ROCE % | 0.79 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 24.48 | |||||
PE Ratio without NRI | 29.28 | |||||
Shiller PE Ratio | 10.29 | |||||
PEG Ratio | 0.9 | |||||
PS Ratio | 3.48 | |||||
PB Ratio | 0.82 | |||||
Price-to-Tangible-Book | 0.88 | |||||
Price-to-Operating-Cash-Flow | 11.72 | |||||
EV-to-EBIT | 69.5 | |||||
EV-to-EBITDA | 69.5 | |||||
EV-to-Revenue | 2.63 | |||||
EV-to-FCF | -44.16 | |||||
Price-to-Projected-FCF | 0.73 | |||||
Price-to-DCF (Earnings Based) | 0.95 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.19 | |||||
Price-to-Graham-Number | 1.08 | |||||
Price-to-Net-Current-Asset-Value | 1.74 | |||||
Price-to-Net-Cash | 19.38 | |||||
Earnings Yield (Greenblatt) % | 1.44 | |||||
FCF Yield % | -1.66 | |||||
Forward Rate of Return (Yacktman) % | 22.17 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Guangdong Hybribio Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 1,104.454 | ||
EPS (TTM) (Â¥) | 0.25 | ||
Beta | 0.73 | ||
Volatility % | 36.29 | ||
14-Day RSI | 40.1 | ||
14-Day ATR (Â¥) | 0.260772 | ||
20-Day SMA (Â¥) | 6.6175 | ||
12-1 Month Momentum % | -24.62 | ||
52-Week Range (Â¥) | 5.65 - 11.19 | ||
Shares Outstanding (Mil) | 646.5 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Guangdong Hybribio Biotech Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Guangdong Hybribio Biotech Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Guangdong Hybribio Biotech Co Ltd Frequently Asked Questions
What is Guangdong Hybribio Biotech Co Ltd(SZSE:300639)'s stock price today?
When is next earnings date of Guangdong Hybribio Biotech Co Ltd(SZSE:300639)?
Does Guangdong Hybribio Biotech Co Ltd(SZSE:300639) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |